Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins - PubMed (original) (raw)
. 2005 Mar 4;280(9):7614-23.
doi: 10.1074/jbc.M408714200. Epub 2004 Dec 17.
Affiliations
- PMID: 15611092
- DOI: 10.1074/jbc.M408714200
Free article
Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins
Sayuri Taniguchi et al. J Biol Chem. 2005.
Free article
Abstract
Tau protein is the major component of the intraneuronal filamentous inclusions that constitute defining neuropathological characteristics of Alzheimer's disease and other tauopathies. The discovery of tau gene mutations in familial forms of frontotemporal dementia has established that dysfunction of the tau protein is sufficient to cause neurodegeneration and dementia. Here we have tested 42 compounds belonging to nine different chemical classes for their ability to inhibit heparin-induced assembly of tau into filaments in vitro. Several phenothiazines (methylene blue, azure A, azure B, and quinacrine mustard), polyphenols (myricetin, epicatechin 5-gallate, gossypetin, and 2,3,4,2',4'-pentahydroxybenzophenone), and the porphyrin ferric dehydroporphyrin IX inhibited tau filament formation with IC(50) values in the low micromolar range as assessed by thioflavin S fluorescence, electron microscopy, and Sarkosyl insolubility. Disassembly of tau filaments was observed in the presence of the porphyrin phthalocyanine. Compounds that inhibited tau filament assembly were also found to inhibit the formation of Abeta fibrils. Biochemical analysis revealed the formation of soluble oligomeric tau in the presence of the inhibitory compounds, suggesting that this may be the mechanism by which tau filament formation is inhibited. The compounds investigated did not affect the ability of tau to interact with microtubules. Identification of small molecule inhibitors of heparin-induced assembly of tau will form a starting point for the development of mechanism-based therapies for the tauopathies.
Similar articles
- Biochemistry and molecular biology of tauopathies.
Hasegawa M. Hasegawa M. Neuropathology. 2006 Oct;26(5):484-90. doi: 10.1111/j.1440-1789.2006.00666.x. Neuropathology. 2006. PMID: 17080729 Review. - Small molecule inhibitors of alpha-synuclein filament assembly.
Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, Iwatsubo T, Hisanaga S, Goedert M, Hasegawa M. Masuda M, et al. Biochemistry. 2006 May 16;45(19):6085-94. doi: 10.1021/bi0600749. Biochemistry. 2006. PMID: 16681381 - Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain.
Hattori M, Sugino E, Minoura K, In Y, Sumida M, Taniguchi T, Tomoo K, Ishida T. Hattori M, et al. Biochem Biophys Res Commun. 2008 Sep 12;374(1):158-63. doi: 10.1016/j.bbrc.2008.07.001. Epub 2008 Jul 9. Biochem Biophys Res Commun. 2008. PMID: 18619417 - Taxol-stabilized microtubules promote the formation of filaments from unmodified full-length Tau in vitro.
Duan AR, Goodson HV. Duan AR, et al. Mol Biol Cell. 2012 Dec;23(24):4796-806. doi: 10.1091/mbc.E12-05-0374. Epub 2012 Oct 19. Mol Biol Cell. 2012. PMID: 23087208 Free PMC article. - Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
Goedert M, Spillantini MG. Goedert M, et al. Biochim Biophys Acta. 2000 Jul 26;1502(1):110-21. doi: 10.1016/s0925-4439(00)00037-5. Biochim Biophys Acta. 2000. PMID: 10899436 Review.
Cited by
- Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.
Shimonaka S, Matsumoto SE, Elahi M, Ishiguro K, Hasegawa M, Hattori N, Motoi Y. Shimonaka S, et al. J Biol Chem. 2020 Oct 9;295(41):13996-14014. doi: 10.1074/jbc.RA120.013271. Epub 2020 Aug 5. J Biol Chem. 2020. PMID: 32759167 Free PMC article. - Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
Hasegawa M. Hasegawa M. Biomolecules. 2016 Apr 28;6(2):24. doi: 10.3390/biom6020024. Biomolecules. 2016. PMID: 27136595 Free PMC article. Review. - Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells.
Dubey T, Gorantla NV, Chandrashekara KT, Chinnathambi S. Dubey T, et al. Sci Rep. 2020 Jul 23;10(1):12380. doi: 10.1038/s41598-020-69403-2. Sci Rep. 2020. PMID: 32704015 Free PMC article. - Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.
Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR. Khanna MR, et al. Alzheimers Dement. 2016 Oct;12(10):1051-1065. doi: 10.1016/j.jalz.2016.06.006. Alzheimers Dement. 2016. PMID: 27751442 Free PMC article. Review. - Acridine derivatives inhibit lysozyme aggregation.
Gazova Z, Bellova A, Daxnerova Z, Imrich J, Kristian P, Tomascikova J, Bagelova J, Fedunova D, Antalik M. Gazova Z, et al. Eur Biophys J. 2008 Sep;37(7):1261-70. doi: 10.1007/s00249-008-0313-0. Epub 2008 Apr 3. Eur Biophys J. 2008. PMID: 18385993
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical